Study reveals short-term blood sugar control protects the kidney but not the heart in patients with diabetes (AlphaGalileo, 6 September 2013)

09 Sept 2013


An international collaboration published in the New England Journal of Medicine assesses cardiovascular outcomes when using saxagliptin in more than 16,000 patients with type 2 diabetes over two years, and across 26 countries.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story